HK1057473A1 - Fatty acid analogues for the treatment of cancer - Google Patents

Fatty acid analogues for the treatment of cancer

Info

Publication number
HK1057473A1
HK1057473A1 HK04100292.1A HK04100292A HK1057473A1 HK 1057473 A1 HK1057473 A1 HK 1057473A1 HK 04100292 A HK04100292 A HK 04100292A HK 1057473 A1 HK1057473 A1 HK 1057473A1
Authority
HK
Hong Kong
Prior art keywords
sub
alkyl
fatty acid
treatment
cancer
Prior art date
Application number
HK04100292.1A
Other languages
English (en)
Inventor
Rolf Berge
Original Assignee
Thia Medica As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica As filed Critical Thia Medica As
Publication of HK1057473A1 publication Critical patent/HK1057473A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK04100292.1A 2000-07-13 2004-01-15 Fatty acid analogues for the treatment of cancer HK1057473A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20003591A NO20003591L (no) 2000-07-13 2000-07-13 Fettsyreanaloger for behandling av kreft
PCT/NO2001/000301 WO2002003983A1 (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer

Publications (1)

Publication Number Publication Date
HK1057473A1 true HK1057473A1 (en) 2004-04-08

Family

ID=19911376

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04100292.1A HK1057473A1 (en) 2000-07-13 2004-01-15 Fatty acid analogues for the treatment of cancer

Country Status (18)

Country Link
US (1) US7378443B2 (xx)
EP (1) EP1313463B1 (xx)
JP (1) JP2004502732A (xx)
KR (2) KR100861428B1 (xx)
CN (1) CN100569228C (xx)
AT (1) ATE320802T1 (xx)
AU (2) AU7286001A (xx)
BR (1) BR0112399A (xx)
CA (1) CA2414480A1 (xx)
DE (1) DE60118198T2 (xx)
ES (1) ES2261441T3 (xx)
HK (1) HK1057473A1 (xx)
MX (1) MXPA02012944A (xx)
NO (2) NO20003591L (xx)
NZ (1) NZ523316A (xx)
RU (1) RU2283105C2 (xx)
WO (1) WO2002003983A1 (xx)
ZA (1) ZA200210028B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
AU2003278602C1 (en) 2002-06-20 2010-08-12 Pronova Biopharma Norge As Sulfur-containing phospholipid derivatives
US7659242B2 (en) 2004-07-19 2010-02-09 Thia Medica As Composition comprising protein material and compounds comprising non-oxidizable fatty acid entities
NO20053519L (no) * 2005-07-18 2007-01-19 Thia Medica As Anvendelse av forbindelser som omfatter fettsyrer
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
US8650937B2 (en) 2008-09-19 2014-02-18 Tandem Diabetes Care, Inc. Solute concentration measurement device and related methods
AU2010278894B2 (en) 2009-07-30 2014-01-30 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
AU2014228387B2 (en) 2013-03-11 2016-09-01 Sciadonics, Inc. Lipid compositions containing bioactive fatty acids
WO2014140934A2 (en) 2013-03-11 2014-09-18 Life Science Nutrition As Natural lipids containing non-oxidizable fatty acids
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
DE102014116958B9 (de) * 2014-11-19 2017-10-05 Trumpf Laser- Und Systemtechnik Gmbh Optisches System zur Strahlformung eines Laserstrahls, Laserbearbeitungsanlage, Verfahren zur Materialbearbeitung und Verwenden einer gemeinsamen langgezogenen Fokuszone zur Lasermaterialbearbeitung
US20180169159A1 (en) * 2015-06-11 2018-06-21 University Of Miami Cancer treatment and diagnosis
CN105498622B (zh) * 2015-12-10 2017-10-17 江南大学 一种含硒表面活性剂及其制备方法和应用
CN107235880B (zh) * 2017-06-30 2018-10-30 江南大学 一种含硒阳离子表面活性剂及其应用
GB201910644D0 (en) * 2019-07-25 2019-09-11 Coegin Pharma As Cancer Treatment
US11897888B1 (en) 2020-04-30 2024-02-13 Stinginn Llc Small molecular inhibitors of sting signaling compositions and methods of use
CN115260964A (zh) * 2022-08-29 2022-11-01 烟台市福山义昌精细化工厂 一种石油油管丝扣专用密封胶及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686377B2 (ja) * 1985-09-30 1994-11-02 日清製粉株式会社 がん転移抑制剤
JPH0797320A (ja) * 1993-08-04 1995-04-11 Takuma Sasaki 制癌剤
US6358915B1 (en) * 1995-03-07 2002-03-19 George Washington University Methods for inhibiting metastasis
ATE223713T1 (de) * 1995-04-10 2002-09-15 Taiho Pharmaceutical Co Ltd Inhibitor der krebsmetastasierung
NO952796D0 (no) * 1995-07-14 1995-07-14 Rolf Berge Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater
WO1999058120A1 (en) * 1998-05-08 1999-11-18 Rolf Berge USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
JP4993878B2 (ja) * 2005-06-28 2012-08-08 ダイキョーニシカワ株式会社 多気筒エンジンの吸気装置

Also Published As

Publication number Publication date
KR20080071598A (ko) 2008-08-04
DE60118198T2 (de) 2007-01-25
ES2261441T3 (es) 2006-11-16
US7378443B2 (en) 2008-05-27
AU2001272860B2 (en) 2005-11-24
WO2002003983A1 (en) 2002-01-17
JP2004502732A (ja) 2004-01-29
KR20030016399A (ko) 2003-02-26
EP1313463B1 (en) 2006-03-22
CN100569228C (zh) 2009-12-16
US20040024063A1 (en) 2004-02-05
ATE320802T1 (de) 2006-04-15
DE60118198D1 (de) 2006-05-11
NZ523316A (en) 2004-09-24
MXPA02012944A (es) 2004-05-17
CA2414480A1 (en) 2002-01-17
CN1441671A (zh) 2003-09-10
ZA200210028B (en) 2004-01-26
AU7286001A (en) 2002-01-21
BR0112399A (pt) 2003-05-27
RU2283105C2 (ru) 2006-09-10
KR100861428B1 (ko) 2008-10-02
NO20025930L (no) 2003-01-13
NO20003591L (no) 2002-01-14
NO20003591D0 (no) 2000-07-13
NO20025930D0 (no) 2002-12-11
NO324634B1 (no) 2007-11-26
EP1313463A1 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
AU7286001A (en) Fatty acid analogues for the treatment of cancer
HK1034911A1 (en) Novel fatty acid analogues for the treatment of secondary restenosis
ZA854857B (en) Tropical treatment and composition
MX9804105A (es) Antagonistas de taquicininas a base de piperidonas.
AU9441901A (en) Fatty acid analogues for the treatment of proliferative skin disorders
YU53402A (sh) Preparat
MY141869A (en) Mouth rinse compositions
JP2004502732A5 (xx)
NO953099D0 (no) Acylfulven analoger som antitumor midler
RU2002134754A (ru) Аналоги жирных кислот для лечения рака
IL137964A0 (en) Antitumor agents
MY133299A (en) Skin moisturizing composition comprising a choline salt
GR970100409A (el) Βελτιωσεις στην προληψη του καρκινου του μαστου και σε σχεση με αυτην
DE69839781D1 (en) Heterocyclische topoisomerase toxine
MY129176A (en) Tetrahydro gamma-carbolines
WO2004080408A3 (en) Method of treating cancer with azaspirane compositions
CA2220024A1 (en) Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
TW200724131A (en) Antibacterial 5,5'-disubstituted 3,3'-dialkoxy-2,2'-dihydroxy-1,1'-biphenyl compounds and related methods
EP0781667A3 (en) Reversible thermochromic composition
CA2361605A1 (en) Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases
IL150274A0 (en) Process for the preparation of pyrazolopyridazine derivatives
TR200100070A2 (tr) Bileşim
NZ517855A (en) Indeno[1,2-b]indol-10(5H)-one compounds and pharmaceutical compositions containing them
KR950008515A (ko) 피리도[1,2,3-d,e][1,3,4] 벤족사디아진 유도체
MXPA04001247A (es) Reduccion del crecimiento del vello.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140713